Analytical review of Tiryāq-i-Wabāī - A Unani panacea for the control of COVID-19.

Research is underway to find effective treatments for COVID-19. Scientists are exploring traditional systems like Unani formulation, which has been used in cholera and other epidemics. A review aims to analyze the potential of Unani formulation in preventing and controlling COVID-19.

Anwar N et al (2023).

J Herb Med.

DOI:

10.1016/j.hermed.2023.100653

PubMed:

37073363

Case Report: Psychiatric Symptoms Associated With the Moderna mRNA COVID-19 Vaccine Administration and Their Resolution.

Psychiatric symptoms emerged post-Moderna mRNA vaccination in a patient, effectively treated with St. John's wort. Hypericin in the herb may sensitize post-vaccine administration, highlighting implications for self-medication in mild depression.

Helman DS et al (2023).

Clin Med Insights Case Rep.

DOI:

10.1177/11795476231166626

PubMed:

37065637

Deciphering Houttuynia cordata extract as electron shuttles with anti-COVID-19 activity and its performance in microbial fuel cells.

Researchers investigated traditional herbal medicines for potential antiviral compounds, focusing on electron shuttle-like structures. They assessed their use in bioenergy extraction and anti-COVID-19 applications, with significant implications for natural antiviral medication development.

Lin CK et al (2023).

J Taiwan Inst Chem Eng.

DOI:

10.1016/j.jtice.2023.104838

PubMed:

37051508

In silico targeting of SARS-CoV-2 spike receptor-binding domain from different variants with chaga mushroom terpenoids.

Amin FG, Elfiky AA and Nassar AM (2024).

J Biomol Struct Dyn.

DOI:

10.1080/07391102.2023.2199084

PubMed:

37042960

A network pharmacology and molecular docking approach in the exploratory investigation of the biological mechanisms of lagundi (Vitex negundo L.) compounds against COVID-19.

Researchers used network pharmacology and molecular docking to identify potential targets of Vitex negundo compounds against COVID-19. Results suggest that these compounds may interact with important proteins involved in the disease. However, further research is needed to fully understand their mechanisms and effectiveness.

Rivera RG et al (2023).

Genomics Inform.

DOI:

10.5808/gi.22060

PubMed:

37037462

Discovery and characterization of the covalent SARS-CoV-2 3CL(pro) inhibitors from Ginkgo biloba extract via integrating chemoproteomic and biochemical approaches.

Study investigates how natural and synthetic compounds modify coronavirus proteases. Identifying herbal constituents that target these proteases is challenging but holds potential for COVID-19 treatment.

Zhang YN et al (2023).

Phytomedicine.

DOI:

10.1016/j.phymed.2023.154796

PubMed:

37037086

Effectiveness of aroma-Tea Tree Oil and Eucalyptus oil in alleviating COVID-19 vaccine discomfort side effects.

Study: Tea Tree and Eucalyptus oils ease post-vaccination discomforts in COVID-19 vaccines. Aromatherapy shows promise as a non-invasive treatment. Positive results suggest potential for alleviating vaccine side effects.

Lee KW et al (2023).

Explore (NY).

DOI:

10.1016/j.explore.2023.03.008

PubMed:

37024404

Psychiatric manifestations of post-COVID-19 syndrome: the potential benefit of Silexan.

Silexan, an essential oil, may alleviate psychiatric symptoms in post-COVID-19 patients, including anxiety, depression, and sleep disturbances, thanks to its neurotrophic and anti-inflammatory properties. It is a safe and well-tolerated therapeutic option.

Kasper S et al (2023).

Int J Psychiatry Clin Pract.

DOI:

10.1080/13651501.2023.2187308

PubMed:

37021969